{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:12:26Z","timestamp":1791364346658,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017025","name":"European Union Geriatric Medicine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001832","name":"Radboud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["948207"],"award-info":[{"award-number":["948207"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["833247"],"award-info":[{"award-number":["833247"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clim.2023.109762","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:55:05Z","timestamp":1694001305000},"page":"109762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses"],"prefix":"10.1016","volume":"255","author":[{"given":"Konstantin","family":"F\u00f6hse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fcsra","family":"Geckin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Zoodsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger J.","family":"R\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs J.","family":"Overheul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"van de Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobien J.","family":"Hoogerwerf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"ten Oever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elles","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Schaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortwin","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp Niklas","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L.","family":"Haagmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinout","family":"van Crevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"van Rij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine","family":"GeurtsvanKessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Dom\u00ednguez-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109762_bb0005","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0010","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","author":"Sahin","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109762_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"IScience."},{"key":"10.1016\/j.clim.2023.109762_bb0025","first-page":"596","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"410","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.clim.2023.109762_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010830","article-title":"Igy\u00e1 Rt\u00f3 id, pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion","volume":"18","author":"Qin","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2023.109762_bb0035","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2023.109762_bb0040","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.cell.2021.05.039","article-title":"The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination","volume":"184","author":"Wimmers","year":"2021","journal-title":"Cell."},{"key":"10.1016\/j.clim.2023.109762_bb0045","article-title":"Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine","author":"Murphy","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109762_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/v13020282","article-title":"Berberine and Obatoclax inhibit SARS-Cov-2 replication in primary human nasal epithelial cells in vitro","volume":"13","author":"Varghese","year":"2021","journal-title":"Viruses."},{"issue":"1","key":"10.1016\/j.clim.2023.109762_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25949-x","article-title":"SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms","volume":"12","author":"Fr\u00f6berg","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2023.109762_bb0060","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jiaa479","article-title":"SARS-CoV-2\u2013specific antibody detection for Seroepidemiology: a multiplex analysis approach accounting for accurate Seroprevalence","volume":"222","author":"Den Hartog","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2023.109762_bb0065","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106230","article-title":"SARS-CoV-2 targets neurons of 3D human brain organoids","volume":"39","author":"Ramani","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2023.109762_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jviromet.2010.11.024","article-title":"Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus","volume":"171","author":"Grund","year":"2011","journal-title":"J. Virol. Methods"},{"issue":"3","key":"10.1016\/j.clim.2023.109762_bb0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.clim.2023.109762_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nbt.3820","article-title":"Nextflow enables reproducible computational workflows","volume":"35","author":"Tommaso","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.clim.2023.109762_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.clim.2023.109762_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat. Immunol."},{"issue":"2020","key":"10.1016\/j.clim.2023.109762_bb0100","first-page":"718","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"1979","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clim.2023.109762_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-34895-1","article-title":"Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity","volume":"13","author":"Smith","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2023.109762_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/vaccines10020171","article-title":"Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine","volume":"10","author":"Gandolfo","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.clim.2023.109762_bb0115","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0120","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0125","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1515\/cclm-2022-0212","article-title":"Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals","volume":"60","author":"Salvagno","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0130","article-title":"Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 omicron infection","volume":"40","author":"Teresa Vietri","year":"2022","journal-title":"Vaccine."},{"key":"10.1016\/j.clim.2023.109762_bb0135","article-title":"mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant","volume":"3","author":"Edara","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0140","doi-asserted-by":"crossref","first-page":"eabo2202","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS-CoV-2 omicron-reactive T and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.clim.2023.109762_bb0145","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 omicron variant","volume":"94","author":"Tian","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.clim.2023.109762_bb0150","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.3389\/fimmu.2021.830527","article-title":"Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies","volume":"12","author":"Shah","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109762_bb0155","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.15585\/mmwr.mm7148e1","article-title":"Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection - increasing community access to testing program, United States, September-November 2022","volume":"71","author":"Link-Gelles","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.clim.2023.109762_bb0160","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.15585\/mmwr.mm715152e1","article-title":"Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19\u2013associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults \u2014 VISION network, nine states, September\u2013November 2022","volume":"71","author":"Tenforde","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.clim.2023.109762_bb0165","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.15585\/mmwr.mm715152e2","article-title":"Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19\u2013associated hospitalization among immunocompetent adults aged \u226565 years \u2014 IVY network, 18 states, September 8\u2013November 30, 2022","volume":"71","author":"Surie","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.clim.2023.109762_bb0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMc2213948","article-title":"Immunogenicity of BA.5 bivalent mRNA vaccine boosters","volume":"388","author":"Collier","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMc2213907","article-title":"Antibody response to omicron BA.4\u2013BA.5 bivalent booster","volume":"388","author":"Wang","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102190","article-title":"Trained immunity: implications for vaccination","volume":"77","author":"Geckin","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2023.109762_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2023.109762_bb0190","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2023.109762_bb0195","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163347","article-title":"Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells","author":"Yamaguchi","year":"2022","journal-title":"JCI Insight."},{"key":"10.1016\/j.clim.2023.109762_bb0200","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1126\/scitranslmed.abi8961","article-title":"Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals","volume":"14","author":"Samanovic","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.clim.2023.109762_bb0210","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2023.109762_bb0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2023.109762_bb0220","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2023.109762_bb0225","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of Pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clim.2023.109762_bb0230","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/274923a0","article-title":"Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes","volume":"274","author":"Dimitriadis","year":"1978","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109762_bb0235","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2023.109762_bb0240","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/274921a0","article-title":"Evidence for translation of rabbit globin mRNA after liposome-mediated insertion into a human cell line","volume":"274","author":"Ostro","year":"1978","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109762_bb0245","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs."},{"key":"10.1016\/j.clim.2023.109762_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity."},{"key":"10.1016\/j.clim.2023.109762_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13010045","article-title":"Nanoparticles as adjuvants and Nanodelivery systems for mRNA-based vaccines","volume":"13","author":"Alfagih","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.clim.2023.109762_bb0260","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","article-title":"The systemic toxicity of positively charged lipid nanoparticles and the role of toll-like receptor 4 in immune activation","volume":"31","author":"Kedmi","year":"2010","journal-title":"Biomaterials."},{"key":"10.1016\/j.clim.2023.109762_bb0265","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and Challenges in the Delivery of mRNA-Based Vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clim.2023.109762_bb0270","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/vaccines11020232","article-title":"COVID-19, SARS-CoV-2 Vaccination, and human herpesviruses infections","volume":"11","author":"Maple","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.clim.2023.109762_bb0275","first-page":"573","article-title":"Hepatitis C virus reactivation following COVID-19 vaccination - a case report","volume":"14","author":"Lensen","year":"2021","journal-title":"Int. Med. Case Rep. J."},{"key":"10.1016\/j.clim.2023.109762_bb0280","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)00623-6","article-title":"Reactivation of herpesvirus infections after vaccinations?","volume":"353","author":"Walter","year":"1999","journal-title":"Lancet."},{"key":"10.1016\/j.clim.2023.109762_bb0285","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICO.0000000000002537","article-title":"Presumed herpes zoster Ophthalmicus reactivation following recombinant zoster vaccination","volume":"40","author":"Jabbour","year":"2021","journal-title":"Cornea."},{"key":"10.1016\/j.clim.2023.109762_bb0290","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/cid\/ciac327","article-title":"Coronavirus Disease 2019 Vaccine boosting in previously infected or vaccinated individuals","volume":"75","author":"Shrestha","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2023.109762_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00058-0","article-title":"Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study","author":"Chemaitelly","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.clim.2023.109762_bb0300","doi-asserted-by":"crossref","first-page":"e2225320","DOI":"10.1001\/jamanetworkopen.2022.25320","article-title":"Rate of SARS-CoV-2 reinfection during an omicron wave in Iceland","volume":"5","author":"Eythorsson","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.clim.2023.109762_bb0305","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad209","article-title":"Effectiveness of the coronavirus Disease 2019 bivalent vaccine","volume":"10","author":"Shrestha","year":"2023","journal-title":"Open Forum. Infect. Dis."},{"key":"10.1016\/j.clim.2023.109762_bb0310","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1056\/NEJMoa2201570","article-title":"Protection by a fourth dose of BNT162b2 against omicron in Israel","volume":"386","author":"Bar-On","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109762_bb0315","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.3389\/fimmu.2022.904686","article-title":"The robustness of cellular immunity determines the fate of SARS-CoV-2 infection","volume":"13","author":"Moga","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109762_bb0320","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623005259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623005259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:37Z","timestamp":1778616217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623005259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":63,"alternative-id":["S1521661623005259"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109762","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.03.21256520","asserted-by":"object"}]},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109762"}}